European Cancer Organisation
login

EBCC-11 Conference Committees

Organising Committee

  • R. Mansel (United Kingdom) - Conference Chair
  • E. Papadopoulos (Cyprus) - Conference Co-Chair
  • I. Rubio (Spain) - Chair National Organising Committee
  • F. Cardoso (Portugal) - Chair EBCC-10
  • To be confirmed - Chair EBCC-12
  • E. Rutgers (Netherlands) - President EBC Council
  • L. Biganzoli (Italy) - Representative EBC Council
  • H. Bonnefoi (France) - Representative EBC Council
  • R. Britz (Spain) - EUROPA DONNA Representative

 

Scientific Commitee

Risk Factors:

  • J. Cuzick (United Kingdom) - Step Team Leader
  • R. Graffeo (Switzerland) - Member expert
  • K. Benn (Italy) - Member expert
  • M. Schmidt (Netherlands) - Member expert

 

Lifestyle/Prevention including Secondary Prevention:

  • A. Decensi (Italy) - Step Team Leader
  • S. Duffy (United Kingdom) - Member expert
  • S. Knox (Italy) - Member expert
  • I. Romieu (France) - Member expert
  • M. Broeders (Netherlands) - Member expert

 

Optimal Diagnosis:

  • F. Penault-Llorca (France) - Step Team Leader
  • R. Pijnappel (Nethelands) - Member expert
  • H. Junkermann (Germany) - Member expert
  • G. Viale (Italy) - Member expert 
  • S. Erdem (Turkey) - Member expert 

 

Local Regional Treatment:

  • P. Dubsky (Austria) - Step Team Leader
  • Philip Poortmans (Netherlands) - Member expert
  • F. Mac Neill (United Kingdom) - Member expert
  • O. Gentilini (Italy) - Member expert
  • C. Coles (United Kingdom) - Member expert
  • M.J. Vrancken-Peeters (Netherlands) - Member expert

 

Systemic Treatment:

  • L. Biganzoli (Italy) - Step Team Leader
  • M. Piccart (Belgium) - Member expert
  • S. Kyriakides (Cyprus) - Member expert
  • M. Arnedos (France) - Member expert

 

Rehabilitation/Survivorship:

  • O. Pagani (Switzerland) - Step Team Leader
  • N. West (Netherlands) - Member expert
  • T. Spanic (Slovenia) - Member expert
  • F. Peccatori (Italy) - Member expert
  • E. Brain (France) - Member expert

 

Follow up:

  • A. Ponti (Italy) - Step Team Leader
  • G. Pravettoni (Italy) - Member expert
  • E. De Azambuja (Belgium) - Member expert
  • E. Senkus (Poland) - Member expert 
  • R. Britz (Spain) - Member expert 

 

Advanced Disease:

  • D. Cameron (United Kingdom) - Step Team Leader
  • B. Linderholm (Sweden) - Member expert
  • N. Harbeck (United Kingdom) - Member expert
  • G. Curigliano (Italy) - Member expert
  • E. Papadopoulos (Cyprus) - Member expert

 

Supportive and Palliative Care including end of life treatment:

  • T. Saarto (Finland) - Step Team Leader
  • M. Aapro (Switzerland) - Member expert
  • S. Claassen (Netherlands) - Member expert
  • E. Bergsten-Nordstrom (Sweden) - Member expert
  • E. Verschuur (Netherlands) - Member expert
  • C. Ripamonti (Italy) - Member expert

 

Basic and Translational Research:

  • M. Ignatiadis (Belgium) - Step Team Leader
  • F. Andre (France) - Member expert
  • H. Bonnefoi (France) - Member expert
  • J. Martens (Netherlands) - Member expert
  • J. Arribas (Spain) - Member expert
  • M. Wilcox (United Kingdom) - Member expert

 

National Organising Committee

  • I.T. Rubio (Chair) – Hospital Universitario VAll d´Hebro, Barcelona
  • J. Arribas – Vall D´Hebron Institute of Oncology, Barcelona
  • J. Cortes – Hospital Universitario Ramón y Cajal, Madrid
  • M. Espinosa-Bravo – Hospital Universitario Vall d´Hebron, Barcelona
  • A. Esgueva – Hospital Universitario Vall d´Hebron, Barcelona
  • P. Gascon – Hospital Clinic, Barcelona 
  • M. Mollà – Hospital Clinic, Barcelona 
  • V. Peg – Hospital Universitario Vall d´Hebron, Barcelona
  • R. Rodriguez – Hospital Universitario Vall d´Hebron, Barcelona
  • C. Saura – Hospital Universitario Vall d´Hebron, Barcelona
  • R. Salvador – Centro de Diagnóstico por la Imagen-Imagine, Barcelona
  • C. Boronat Jiménez – EUROPA DONNA representative Spain 


 

PRINT THIS PAGE Page last modified: